Si vous ne visualisez pas correctement ce message, cliquez ici
Newsletter #20
January 8th, 2025

Dear all,

Happy New Year! We all want to wish you the best in your personal and professional life. Let's start the year with some opportunities - our PhD grants call opens next week and our equipment call is opening up too! Also don't miss a small but important modification to the eligibility for the postdoc call that ends on March 2nd.

The 2025 equipment call will also be announced soon. Stay tuned!
Sign up for our newsletter
Postdoc call: important notification
Eligibility modification
A small but significant corrections: the co-leaders laureates of previous calls can now apply for this call. Note that in case of a tie they won't be prioritary and the subject and collaboration they present must be different from the project that is already laureate.
Learn more
BioConvS news
Inventors challenge
Défi Inventeur et Inventrice
PhD student? Researcher? Engineer? What if you turned your ideas into concrete invention projects? Are you lacking inspiration, unsure of the invention process, or not familiar with the best practices to protect your creations?
Join the first day taking place on March 20th, and seize this perfect opportunity to get started and bring your ideas to life!
This event will be guided by a collaboration with IP Business Advisors and Legal Experts from INPI and Professor Todd Lubart, an expert in creativity and innovation.
First meeting:
When :
March 20th
Where : 
Learning Planet Institute (8bis rue  Charles V 75004 Paris)
Join
Innovators of tomorrow 2025
Student ? Researcher ? Engineer ? Explore for free  innovation and entrepreneurship to have access to trainings, market studies, innovation tools and more!
The next in-person meeting will take place this Monday, January 13: Meeting with an investor specialized in early-stage investments.
Next event on January 13th
Join
BioConvS calls
Call for Expression of Interest - POD
The POD call for expressions of interest supports innovative biotherapy projects by providing access to cutting-edge technological platforms (IVETH, Magenta/ART-TG, Meary). The goal is to accelerate the transition to clinical trials through specialized expertise in bioproduction and gene therapy.
Learn more
Our 2025 PhD call opens next week
Stay tuned! We're opening very soon our 2025 call for 4 PhD fellowships, deadline April 30th!
Stay tuned
Opportunities
Webinar: call "Digital tools for biomass transformation and bioproduction"
As part of the PEPR B-BEST, a call for projects titled "Digital tools for biomass transformation and bioproduction" is expected to be published soon by the ANR. If you're interested, you can attend an online information seminar about this call on January 21, 2025, from 10:00 AM to 12:00 PM.
More on PEPR B-BEST
Register to the webinar
Apply to the Shaker #16
The Shaker is Genopole's early-stage support program for aspiring entrepreneurs with a biotech idea in healthcare or bioeconomy. This year's wave of applications is open until Feb 3rd. Apply to get lab space, access to cutting-edge platform and business support!
Learn more and apply
Pitch your startup at the Congrès France Bioproduction
The 2025 edition of the Congrès France Bioproduction will be held in Tours on March 19-20. It's time to apply to pitch your startup!
>Is your startup <5 years?
>Do you work in bioproduction?
>>>>>APPLY until Feb 1st
Learn more and apply
SAFE: helping researchers in exile
The European SAFE program will provide up to 60 scholarships of a maximum duration of 24 months to endangered scientists from around the world for a research stay at a European higher education and research institution. The aim is to allow these scientists to escape threats in their home countries and continue their research work safely in an EU member state. The program is intended for researchers at the doctoral level or holders of a doctorate. Please share this opportunity!
Apply
Get free access to the ISCT Advanced Cell Therapy Manufacturing and Regulatory Course
A few individual yearly licenses are still available for of our Basic Lab Membership You can apply to access the ISCT network and training material, which notably includes the Advanced Cell Therapy Manufacturing and Regulatory Course, and much more!
Learn more and apply
ANR Call for Industrial Chairs 2025
The ANR Industrial Chairs program fosters public-private collaboration through ambitious, innovative research projects in strategic fields. Open to all disciplines, it supports renowned researchers and doctoral training. Funding is available for up to 48 months, matched by contributions from partner companies.
Learn more
Might interest you
The EIC Tech Report 2024 is out
Read about key emerging technologies for the future competitiveness of European industry
Read more
PSCC Innovation Forum 2025
Join the Paris-Saclay Cluster Innovation Forum, attend scientific conferences, and watch startup pitches from the PSCC! This event is dedicated to oncology innovation, scientific discovery, and exchanges with key players in our ecosystem.
Register
>When: February 4th
>Where: 3 bd Chastenet de Géry, Villejuif

Job opportunities
An engineer position in characterisation of biological nanoobjects in biological fluids is open at our very own iVETH integrator. Learn more

Several offers are open at the ART-TG of Anne Galy:

A post-doctoral position to study immunotherapy with engineered B cells in conjunction with IMRB in Créteil. Learn more

A project manager position is open to establish a platform specializing in genome editing and preclinical studies at ART-TG within the context of the GENOTHER biocluster. Learn more

A scientific project manager position is open to pilot research and preclinincal projects carried out at the ART-TG biotherapy and bioproduction integrator. Learn more
Join BioConvS
Census of BioConvS labs
Starting January 2024, all labs affiliated or wanting to participate in a DIM BioConvS activity will have to be registered. Why? Most importantly because we want to build a cartography of biotherapy, bioproduction and synthetic biology in Ile-de-France and you want to make sure that you're on it!
Fill in the affiliation form
Last but not least...
...a big THANK YOU to Région Ile de France for prioritizing research and innovation🌟
In a challenging period marked by significant budget cuts, the Région Île-de-France has once again demonstrated its strong commitment to the future by placing the DIMs among its 7 top priorities for 2025! 🙌
We at DIM BioConvS are deeply grateful for this recognition and unwavering support. This decision not only safeguards funding for cutting-edge research but also reaffirms the region’s leadership in fostering innovation in bioproduction, biotherapy, and synthetic biology.
Discover Ile-de-France's top priorities for 2025
Recent publications
Do you want to see your paper featured in our next newlsetter? Write to chiara.fracassi@u-paris.fr

Alric, H., Mathieu, N., Sebbagh, A., Peré, G., Demarquay, C., Cronemberger, A., Berger, A., Marcel, B., Wilhelm, C., Gazeau, F., Mariani, A., Karoui, M., Clément, O., Araujo-Filho, I., Silva, A.K.A., Rahmi, G., 2024. Thermoresponsive gel embedding extracellular vesicles from adipose stromal cells improves the healing of colonic anastomoses following irradiation in rats. Commun Biol 7, 1–12. https://doi.org/10.1038/s42003-024-07364-2

Carr, C.M., Harkova, L.G., McCarthy, R.R., 2024. Engineering biology approaches to modulate bacterial biofilms. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2024.11.002

Mallozzi, A., Fusco, V., Ragazzini, F., di Bernardo, D., 2024. A Biomolecular Circuit for Automatic Gene Regulation in Mammalian Cells with CRISPR Technology. ACS Synth. Biol. https://doi.org/10.1021/acssynbio.4c00225

Monier, M., Lorenzi, J.-N., Narasimha, S., Borne, F., Contremoulins, V., Mevel, L., Petit, R., El Hachem, Y., Graner, F., Courtier-Orgogozo, V., 2024. Adhesive and mechanical properties of the glue produced by 25 Drosophila species. Sci Rep 14, 23249. https://doi.org/10.1038/s41598-024-74358-9

Mormin, M., Rigonnot, L., Chalumeau, A., Miccio, A., Fournier, C., Pajanissamy, S., Dewannieux, M., Galy, A., 2024. Cyclosporin H Improves the Transduction of CD34 Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease. Human Gene Therapy 35, 896–903. https://doi.org/10.1089/hum.2024.098

Río, P., Zubicaray, J., Navarro, S., Gálvez, E., Sánchez-Domínguez, R., Nicoletti, E., Sebastián, E., Rothe, M., Pujol, R., Bogliolo, M., John-Neek, P., Bastone, Antonella Lucía, Schambach, A., Wang, W., Schmidt, M., Larcher, L., Segovia, J.C., Yáñez, R.M., Alberquilla, O., Díez, B., Fernández-García, M., García-García, L., Ramírez, M., Galy, A., Lefrere, F., Cavazzana, M., Leblanc, T., García de Andoin, N., López-Almaraz, R., Catalá, A., Barquinero, J., Rodríguez-Perales, S., Rao, G., Surrallés, J., Soulier, J., Díaz-de-Heredia, C., Schwartz, J.D., Sevilla, J., Bueren, J.A., Río, P., Zubicaray, J., Navarro, S., Gálvez, E., Sánchez-Domínguez, R., Nicoletti, E., Sebastián, E., Rothe, M., Pujol, R., Bogliolo, M., John-Neek, P., Bastone, Antonella L, Schambach, A., Wang, W., Schmidt, M., Larcher, L., Segovia, J.C., Yáñez, R.M., Pérez-Maroto, F., de la Cruz, A., Casado, J.A., Giménez, Y., Álvarez, L., Alberquilla, O., Díez, B., Fernández-García, M., García-García, L., Gómez, A., Galán, A., Ramírez, M., Salgado, R., Galy, A., Lefrere, F., Cavazzana, M., Leblanc, T., Garcia de Andoin, N., López-Almaraz, R., Catalá, A., Barquinero, J., Rodríguez-Perales, S., Rao, G., Surrallés, J., Soulier, J., Díaz-de-Heredia, C., Schwartz, J.D., Sevilla, J., Bueren, J.A., 2024. Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials. The Lancet 404, 2584–2592. https://doi.org/10.1016/S0140-6736(24)01880-4

Thouvenot, E., Charnay, L., Burshtein, N., Guigner, J.-M., Dec, L., Loew, D., Silva, A.K.A., Lindner, A., Wilhelm, C., n.d. High-Yield Bioproduction of Extracellular Vesicles from Stem Cell Spheroids via Millifluidic Vortex Transport. Advanced Materials n/a, 2412498. https://doi.org/10.1002/adma.202412498
Not on our list yet? Subscribe to the DIM Newsletter
Too many emails? Edit your preferences or unsubscribe from our list:
Pour vous désinscrire, cliquer ici
 
Action financée par la Région Île-de-France